Bill Gates shared insights into his new Netflix series, "What's Next? The Future with Bill Gates," where he discusses future ...

Jim Cramer, the host of CNBC’s “Mad Money,” is known for his energetic and often controversial takes on the stock market.

Trump's ownership of a media company and publicly traded company is raising ethics concerns ahead of the 2024 election.

Novo Nordisk announced Phase 2a trial results for monlunabant. The trial demonstrated a weight reduction of 7.1 kg with a 10 ...

SkyBridge Capital founder Anthony Scaramucci, a headline speaker at Benzinga’s Future of Digital Assets event, is actively ...

Mullen team present in Dubai this week for delivery of first EV vehicles. Mullen recently executed a 1-for-100 reverse stock ...

Microsoft announces the end of its Xbox Ambassadors program after 13 years, with the website shutting down Oct. 15.

Gartner IT has outperformed the market over the past 15 years by 13.06% on an annualized basis producing an average annual ...

Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose.

The union members, most of them based in Washington state, turned down a proposal to raise wages by 25% over four years, as ...

FDA approves Elanco's once-daily oral treatment, Zenrelia, for controlling itching in dogs with allergic and atopic ...

KarXT, a novel schizophrenia drug, is on the verge of FDA approval, promising to revolutionize treatment. However, access ...